Tresiba

Tresiba (insulin deguldec) is a long-acting insulin-based medication used to treat adults with type 1 or type 2 diabetes. It was developed specifically to provide a long-acting insulin medication option that can be taken once a day and acts the same way a basal insulin does. Tresiba remains active and effective for up to 40 hours. This is a significant advantage over similar long-acting insulins that remain active for only 18 to 24 hours.

Tresiba is delivered via a small injection under the skin. The Tresiba injector is a small pen-shaped device that uses a very small needle. There are several dosages available, including the 100 mL per unit (FlexTouch-100), 200 mL per unit (Flex-Touch 200) and U-100 multi-dose pre-filled injectors.